Novo Nordisk and AWS have partnered to establish a new innovation hub in London. This collaboration aims to accelerate drug discovery timelines by leveraging agent-based AI and cloud infrastructure. The initiative has already demonstrated significant efficiency gains, reducing research bureaucracy by over 90%. AI
IMPACT Accelerates drug discovery timelines through AI and cloud infrastructure, potentially reducing research bureaucracy.
RANK_REASON Partnership between a pharmaceutical company and a cloud provider to use AI for a specific application.
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
